Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948798034> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2948798034 endingPage "2187" @default.
- W2948798034 startingPage "2181" @default.
- W2948798034 abstract "Abstract Objective The objective was to determine the proportion of patients with difficult-to-treat or difficult-to-prevent acute gout attacks eligible for IL-1 inhibition. Methods Participants included in the French cross-sectional GOSPEL cohort (n = 1003 gout patients) were examined for contraindications and intolerance to standard of care (SoC) drugs of gout flares (colchicine, non-steroidal anti-inflammatory drugs and systemic glucocorticoids). Patients were classified as definitely eligible for first-line IL-1 inhibition (canakinumab) according to European summary of product characteristics (contraindications/intolerance to SoC and at least three flares per year) without any other anti-inflammatory options (contraindications/intolerance only), or potentially eligible (precaution of use). Eligibility to receive IL-1 during an on-going flare related to insufficient efficacy was assessed (second-line eligibility). Results Definite first-line eligibility for IL-1 therapy was found in 10 patients (1%) and contraindication to all SoC therapies in nine patients who had presented <3 flares in the past 12 months. At least precaution of use for SoC therapies was noted for 218/1003 patients (21.7%). Of 487 patients experiencing flares at baseline, 114 (23.4%) were still experiencing pain scored ⩾4/10 numeric scale on day 3, one of whom could not receive further SoC drugs. Only nine of them had three or more flares in the past year and were eligible for second-line IL-1 inhibition. Conclusion Despite significant numbers of patients without any SoC anti-inflammatory therapeutic options for gout flares, eligibility for IL-1 inhibition therapy according to current European approval is rare." @default.
- W2948798034 created "2019-06-14" @default.
- W2948798034 creator A5003216259 @default.
- W2948798034 creator A5007352526 @default.
- W2948798034 creator A5008484376 @default.
- W2948798034 creator A5024599558 @default.
- W2948798034 creator A5060186682 @default.
- W2948798034 creator A5064836713 @default.
- W2948798034 date "2019-06-09" @default.
- W2948798034 modified "2023-10-18" @default.
- W2948798034 title "Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval" @default.
- W2948798034 cites W1964105170 @default.
- W2948798034 cites W2003168056 @default.
- W2948798034 cites W2023421402 @default.
- W2948798034 cites W2027100907 @default.
- W2948798034 cites W2067732852 @default.
- W2948798034 cites W2094780098 @default.
- W2948798034 cites W2111787224 @default.
- W2948798034 cites W2134049088 @default.
- W2948798034 cites W2137091038 @default.
- W2948798034 cites W2138587308 @default.
- W2948798034 cites W2273857554 @default.
- W2948798034 cites W2287877869 @default.
- W2948798034 cites W2335302945 @default.
- W2948798034 cites W2735705864 @default.
- W2948798034 cites W2782615513 @default.
- W2948798034 cites W2797781128 @default.
- W2948798034 cites W2896236948 @default.
- W2948798034 cites W2907058349 @default.
- W2948798034 cites W3014939528 @default.
- W2948798034 cites W4248403572 @default.
- W2948798034 doi "https://doi.org/10.1093/rheumatology/kez203" @default.
- W2948798034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31177284" @default.
- W2948798034 hasPublicationYear "2019" @default.
- W2948798034 type Work @default.
- W2948798034 sameAs 2948798034 @default.
- W2948798034 citedByCount "20" @default.
- W2948798034 countsByYear W29487980342019 @default.
- W2948798034 countsByYear W29487980342020 @default.
- W2948798034 countsByYear W29487980342021 @default.
- W2948798034 countsByYear W29487980342022 @default.
- W2948798034 countsByYear W29487980342023 @default.
- W2948798034 crossrefType "journal-article" @default.
- W2948798034 hasAuthorship W2948798034A5003216259 @default.
- W2948798034 hasAuthorship W2948798034A5007352526 @default.
- W2948798034 hasAuthorship W2948798034A5008484376 @default.
- W2948798034 hasAuthorship W2948798034A5024599558 @default.
- W2948798034 hasAuthorship W2948798034A5060186682 @default.
- W2948798034 hasAuthorship W2948798034A5064836713 @default.
- W2948798034 hasConcept C126322002 @default.
- W2948798034 hasConcept C142724271 @default.
- W2948798034 hasConcept C204787440 @default.
- W2948798034 hasConcept C2776494729 @default.
- W2948798034 hasConcept C2779134260 @default.
- W2948798034 hasConcept C2779725882 @default.
- W2948798034 hasConcept C2780402116 @default.
- W2948798034 hasConcept C2781228260 @default.
- W2948798034 hasConcept C71924100 @default.
- W2948798034 hasConceptScore W2948798034C126322002 @default.
- W2948798034 hasConceptScore W2948798034C142724271 @default.
- W2948798034 hasConceptScore W2948798034C204787440 @default.
- W2948798034 hasConceptScore W2948798034C2776494729 @default.
- W2948798034 hasConceptScore W2948798034C2779134260 @default.
- W2948798034 hasConceptScore W2948798034C2779725882 @default.
- W2948798034 hasConceptScore W2948798034C2780402116 @default.
- W2948798034 hasConceptScore W2948798034C2781228260 @default.
- W2948798034 hasConceptScore W2948798034C71924100 @default.
- W2948798034 hasIssue "12" @default.
- W2948798034 hasLocation W29487980341 @default.
- W2948798034 hasLocation W29487980342 @default.
- W2948798034 hasLocation W29487980343 @default.
- W2948798034 hasOpenAccess W2948798034 @default.
- W2948798034 hasPrimaryLocation W29487980341 @default.
- W2948798034 hasRelatedWork W2008698478 @default.
- W2948798034 hasRelatedWork W2074005273 @default.
- W2948798034 hasRelatedWork W2137507465 @default.
- W2948798034 hasRelatedWork W2324126613 @default.
- W2948798034 hasRelatedWork W2355568291 @default.
- W2948798034 hasRelatedWork W2381280891 @default.
- W2948798034 hasRelatedWork W2416748870 @default.
- W2948798034 hasRelatedWork W2782315116 @default.
- W2948798034 hasRelatedWork W2935681175 @default.
- W2948798034 hasRelatedWork W2948798034 @default.
- W2948798034 hasVolume "58" @default.
- W2948798034 isParatext "false" @default.
- W2948798034 isRetracted "false" @default.
- W2948798034 magId "2948798034" @default.
- W2948798034 workType "article" @default.